New Search

If you are not happy with the results below please do another search

5 search results for:


ProBioGen licenses GlymaxX tech to Sanofi

Berlin-based ProBioGen AG has signed a commercial multi-product license agreement with Sanofi. Under the agreement, Sanofi will integrate ProBioGen’s proprietary GlymaxX technology into their product development strategy for an undisclosed number of antibody candidates across several business units. GlymaxX enables a boost of antibody-dependent cell-mediated cytotoxicity (ADCC), consequently leading to an elevated NK cell mediated […]


AMSBIO offers animal-free enzymes for in-vitro tissue dissociation

AMSBIO, in association with Nordmark Biochemicals, is now offering animal-free Collagenase and Neutral Protease enzymes, isolated from Clostridium histolyticum, for in-vitro tissue dissociation leading to high yields of viable cells. Being animal-free, these enzymes are very safe and offer reduced regulatory hurdles for use in clinical applications. They are manufactured under GMP guidelines using a plant-based […]


Porvair Sciences launches new generation Ultravap Levante nitrogen blowdown sample evaporator

Porvair Sciences has launched its new generation Ultravap Levante nitrogen blowdown sample evaporator. The second generation system offers the many benefits associated with Porvair’s flagship evaporator, the Ultravap Mistral, in an affordable, easy-to-use package. This state-of-the-art single microplate evaporator is designed to meet the current needs of most chromatography laboratories whilst providing the future option of fully automating sample dry-down […]


Researchers devise AI method to speed up protein generation for drug development

Researchers from Chalmers University of Technology, Sweden have developed Artificial Intelligence that is capable of generating novel, functionally active proteins. The research represents a significant breakthrough in the field of synthetic protein development. “What we are now able to demonstrate offers fantastic potential for a number of future applications, such as faster and more cost-efficient development […]


Lonza introduces high-quality cryopreserved Leukopaks

Lonza has expanded its renowned human primary cell offerings with the launch of fully customizable, high-quality cryopreserved Leukopaks. The frozen Leukopaks will enable long-distance shipping of leukapheresis products without the concern of reduced cell viability encountered with fresh Leukopaks. Being suitable for long-term storage in research labs, the cryopreserved Leukopaks will also allow immediate access […]